Aarkstore - Pandemic Influenza-Pipeline Insights, 2014

1
Category Healthcare
Pandemic Influenza-Pipeline Insights, 2014

• Browse Complete Report -
• http//www.aarkstore.com/healthcare/77313/-pandemi
  c-influenza-pipeline-insights-2014

f
2
f
Executive Summary
Pandemic Influenza-Pipeline Insights, 2014,
report provides comprehensive insights about
pipeline drugs across this indication. A key
objective of the report is to establish the
understanding for all the pipeline drugs that
fall under Pandemic Influenza. This report
provides information on the therapeutic
development based on the Pandemic Influenza
dealing with all the pipeline drugs, comparative
analysis at various stages covering Filed, Phase
III, Phase II, Phase I, IND filed, Preclinical,
Discovery and unknown stages, therapeutics
assessment by monotherapy and combination
products and molecule type drug information. The
report also covers the companies information
involved in the therapeutic development of the
products. It also has highlighted the
discontinued and dormant products.
3
f
Data Sources
The report is built using data and information
sourced from proprietary databases, primary and
secondary research and in-house analysis by
DelveInsight team of industry experts.Secondary
sources information and data has been collected
from various printable and non-printable sources
like search engines, News websites, Government
Websites, Trade Journals, White papers,
Magazines, Trade associations, Books, Industry
Portals, Industry Associations and access to
available databases.Note This report requires
certain updates. We have all the information
available but require 3 business days to complete
the process and ensure it is as up-to-date as
possible. Certain sections in the report may be
removed or altered based on the availability and
relevance of data for the indicated Indication.
4
f
Scope 
The report provides a snapshot of the global
therapeutic landscape of Pandemic InfluenzaThe
report provides pipeline products under drug
profile section which includes product
description, MOA, licensors collaborators,
development partner and chemical
informationCoverage of the Pandemic Influenza
pipeline on the basis of target, MOA, route of
administration, technology involved and molecule
typeThe report reviews key players involved in
the therapeutics development for Pandemic
Influenza and also provide company profilingThe
report also gives the information of dormant and
discontinued pipeline projects Pipeline products
coverage based on various stages of development
ranging from preregistration till discovery and
undisclosed stages Provides pipeline assessment
by monotherapy and combination therapy products,
stage of development and molecule type
5
Table of Content

• Pandemic Influenza OverviewPandemic Influenza
  Pipeline TherapeuticsPandemic Influenza
  Therapeutics under Development by
  Companies Pandemic Influenza Late Stage Products
  (Filed and Phase III)Comparative
  Analysis Pandemic Influenza Mid Clinical Stage
  Products (Phase II)Comparative
  Analysis Pandemic Influenza Early Clinical Stage
  Products (Phase I and IND Filed)Comparative
  Analysis Pandemic Influenza Discovery and
  Pre-Clinical Stage Products Comparative
  Analysis Drug Candidate ProfilesPandemic
  Influenza Therapeutics Assessment Assessment by
  Monotherapy Products Assessment by Combination
  Products Assessment by Route of
  Administration Assessment by Molecule
  Type Pandemic Influenza Discontinued
  Products Pandemic Influenza Dormant Products
• Companies Involved in Therapeutics Development
  for Pandemic Influenza Appendix Methodology 

6
f
List Of Tables
Number of Products under Development for Pandemic
Influenza, 2014Number of Products under
Development by Companies Comparative Analysis by
Late Clinical Stage Products (Filed and Phase
III), 2014Comparative Analysis Mid Clinical
Stage Products (Phase II), 2014Comparative
Analysis Early Clinical Stage Products (Phase I
and IND Filed), 2014Comparative Analysis
Discovery and Pre-Clinical Stage Products,
2014Drug Candidates ProfilesPandemic Influenza
Assessment by Monotherapy Products Pandemic
Influenza Assessment by Combination
Products Pandemic Influenza Assessment by Route
of Administration Pandemic Influenza Assessment
by Stage and Route of Administration Pandemic
Influenza Assessment by Molecule Type Pandemic
Influenza Assessment by Stage and Molecule
Type Pandemic Influenza Therapeutics
Discontinued Products Pandemic Influenza
Therapeutics Dormant ProductsProducts under
Development by Companies, 2014
7
List Of Tables

• Number of Products under Development for Pandemic
  Influenza, 2014Late Clinical Stage Products
  (Filed and Phase III), 2014Mid Clinical Stage
  Products (Phase II), 2014Early Clinical Stage
  Products (Phase I and IND Filed), 2014Discovery
  and Pre-Clinical Stage Products, 2014Pandemic
  Influenza Assessment by Monotherapy
  Products Pandemic Influenza Assessment by
  Combination Products Pandemic Influenza
  Assessment by Route of Administration Pandemic
  Influenza Assessment by Stage and Route of
  Administration Pandemic Influenza Assessment by
  Molecule Type Pandemic Influenza Assessment by
  Stage and Molecule Type

8
f
Related Reports
Sjogrens Syndrome Global Clinical Trials Review,
H2, 2014 Human Papillomavirus Infections Global
Clinical Trials Review, H2, 2014 Hospital
Acquired Pneumonia (HAP) Global Clinical Trials
Review, H2, 2014 Influenza A and B Infections
Global Clinical Trials Review, H2, 2014 Empty
Capsules Market by Product (Hard gelatin,
Non-gelatin capsules), Raw Material (Pig meat,
Bovine, HPMC), Therapeutic Application
(Antibiotics, Vitamins) by End User
(Pharmaceutical, Health Supplements) - Global
Forecast to 2019 Acute Asthma Global Clinical
Trials Review, H2, 2014 Global Cystic Fibrosis
Market 2015-2019 CountryFocus Healthcare,
Regulatory and Reimbursement Landscape - South
Africa United States Anesthesia Drugs Market
Forecast Global Type 2 Diabetes Therapeutics
Market 2015-2019
9
f
Pandemic Influenza-Pipeline Insights,
2014 Published Dec. 2014 60 Pages Pandemic
Influenza-Pipeline Insights, 2014, report
provides comprehensive insights about pipeline
drugs across this indication. A key objective of
the report is to establish the understanding for
all the pipeline drugs that fall under Pandemic
Influenza.Price
Format Price
PDF 1250
Site Licence 2500
Enterprise Wide Licence 4000
10
f
Contact Us

• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog
• http//www.aarkstore.com/blog/
• Conference
• http//conference.aarkstore.com/
• News
• http//www.aarkstore.com/news

Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953